In this regard, a larger set of tumor samples from each NSCLC resection should be characterized by ex vivo analysis to contribute to a better understanding of cancer pathogenesis, including the immunological status, and the mechanisms leading to the modulation of PD-L1 expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.